14+ hour, 55+ min ago  (82+ words) Round on the latest news in psychiatry from the last week. For more information on psychedelics in psychiatry, read Psychiatric Times" Psychedelics Special Report. Review the highlights here before the FDA decision. 5. Nonino F, Minozzi S, Sambati L, et al....

22+ hour, 42+ min ago  (224+ words) FDA expands Caplyta label to prevent schizophrenia relapse, cutting risk 63% and showing weight-neutral tolerability for sustained long-term stability. The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (s NDA) based on long-term data evaluating the…...

4+ day, 16+ hour ago  (482+ words) Psychiatry experts explain why off-label psych meds and polypharmacy can be essential. Joseph F. Goldberg, MD, sat down with Henry Nasrallah, MD, to discuss the essentials of off-label prescribing and uses of polypharmacy. Nasrallah highlighted his landmark analysis showing that 88% of…...

1+ mon, 1+ week ago  (410+ words) Guy Goodwin, MD, provides insights into COMP360 psilocybin and recent trial results, as well as psychedelics as a whole and their role in psychiatry. In the ongoing phase 3 COMP006 trial, treatment with the psychedelic COMP360a synthetic, proprietary formulation of psilocybin for managing treatment-resistant…...

2+ mon, 2+ day ago  (426+ words) Early psychosis screening in teens and young adults helps catch overlooked symptoms sooner. Psychiatric Times: We know schizophrenia tends to develop earlier in life; can you share why early screening is so important for schizophrenia and psychosis? 2 PT: When working…...

2+ mon, 2+ week ago  (164+ words) Amidst the resurgence in psychedelics research, a new study evaluated the potential of psychedelics like psilocybin, as well as cannabinoids, to treat obsessive-compulsive disorder. Investigators found potential in psilocybin, but no strong evidence supporting cannabinoids as treatment. Psychiatric Times discussed…...

2+ mon, 2+ week ago  (1144+ words) So Desiree, we still have a big problem with treating depressed patients. We have at least two major unmet needs, it seems to be. One is that people can't get access to care, and even if they can get the…...

2+ mon, 3+ week ago  (156+ words) Explore insights on bipolar disorder, including suicide risk assessment and comorbidities. Share your insights and experiences today with our February theme! Psychiatric Times features monthly themes that speak to various aspects of psychiatry and issues relevant to psychiatric clinicians. Our…...

2+ mon, 4+ week ago  (408+ words) Psychiatric Times This video series is taking a short break while Dr Moffic travels. For now, enjoy the rerun of this video with updated commentary. It would be hard to deny that this past year has been one of the…...

3+ mon, 14+ hour ago  (513+ words) Anti-inflammatory treatment was found to reduce depressive symptoms and anhedonia in selected patients, in a meta-analysis of controlled trials with cohorts exhibiting an inflammatory phenotype. 1 Mac Giollabhui discussed the utility of CRP levels in identifying inflammatory phenotype among individuals with…...